Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000914208-25-000192
Filing Date
2025-05-09
Accepted
2025-05-09 16:14:39
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5493
2 JOINT FILING AGREEMENT Rule13D_JointFilingAgreement.htm EX-99 5781
  Complete submission text file 0000914208-25-000192.txt   13483
Mailing Address 1331 SPRING STREET NW SUITE 2500 ATLANTA GA 30309
Business Address 1331 SPRING STREET NW SUITE 2500 ATLANTA GA 30309 404-892-0896
Invesco Ltd. (Filed by) CIK: 0000914208 (see all company filings)

EIN.: 980557567 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: SCHEDULE 13G
SIC: 6282 Investment Advice
(CF Office: 02 Finance)

Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Subject) CIK: 0001368514 (see all company filings)

EIN.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-82025 | Film No.: 25930584
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)